Identification of Cathepsin L as the molecular target of hydroxychloroquine with chemical proteomics

DOI record: { "DOI": "10.1016/j.mcpro.2025.101314", "ISSN": [ "1535-9476" ], "URL": "http://dx.doi.org/10.1016/j.mcpro.2025.101314", "alternative-id": [ "S153594762500413X" ], "article-number": "101314", "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Identification of Cathepsin L as the molecular target of hydroxychloroquine with chemical proteomics" }, { "label": "Journal Title", "name": "journaltitle", "value": "Molecular & Cellular Proteomics" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.mcpro.2025.101314" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "® 2025 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology." } ], "author": [ { "affiliation": [], "family": "Shang", "given": "Jin", "sequence": "first" }, { "ORCID": "https://orcid.org/0000-0002-6677-9454", "affiliation": [], "authenticated-orcid": false, "family": "Hu", "given": "Bingjie", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-2732-4369", "affiliation": [], "authenticated-orcid": false, "family": "Kung", "given": "Ka-Yan Karen", "sequence": "additional" }, { "affiliation": [], "family": "Jiang", "given": "Jiajun", "sequence": "additional" }, { "affiliation": [], "family": "Zhang", "given": "Qi", "sequence": "additional" }, { "affiliation": [], "family": "Wong", "given": "Man-Kin", "sequence": "additional" }, { "affiliation": [], "family": "Chu", "given": "Hin", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0003-2244-6516", "affiliation": [], "authenticated-orcid": false, "family": "Zhao", "given": "Qian", "sequence": "additional" } ], "container-title": "Molecular & Cellular Proteomics", "container-title-short": "Molecular & Cellular Proteomics", "content-domain": { "crossmark-restriction": true, "domain": [ "mcponline.org", "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2025, 10, 18 ] ], "date-time": "2025-10-18T22:39:20Z", "timestamp": 1760827160000 }, "deposited": { "date-parts": [ [ 2025, 10, 18 ] ], "date-time": "2025-10-18T22:39:24Z", "timestamp": 1760827164000 }, "indexed": { "date-parts": [ [ 2025, 10, 18 ] ], "date-time": "2025-10-18T23:10:30Z", "timestamp": 1760829030139, "version": "build-2065373602" }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2025, 10 ] ] }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 10, 1 ] ], "date-time": "2025-10-01T00:00:00Z", "timestamp": 1759276800000 } }, { "URL": "https://www.elsevier.com/legal/tdmrep-license", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 10, 1 ] ], "date-time": "2025-10-01T00:00:00Z", "timestamp": 1759276800000 } }, { "URL": "http://creativecommons.org/licenses/by/4.0/", "content-version": "vor", "delay-in-days": 16, "start": { "date-parts": [ [ 2025, 10, 17 ] ], "date-time": "2025-10-17T00:00:00Z", "timestamp": 1760659200000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S153594762500413X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S153594762500413X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "101314", "prefix": "10.1016", "published": { "date-parts": [ [ 2025, 10 ] ] }, "published-print": { "date-parts": [ [ 2025, 10 ] ] }, "publisher": "Elsevier BV", "reference": [ { "DOI": "10.1021/jm990437l", "article-title": "Structure− function relationships in aminoquinolines: effect of amino and chloro groups on quinoline− hematin complex formation, inhibition of β-hematin formation, and antiplasmodial activity", "author": "Egan", "doi-asserted-by": "crossref", "first-page": "283", "issue": "2", "journal-title": "Journal of medicinal chemistry", "key": "10.1016/j.mcpro.2025.101314_bib1", "volume": "43", "year": "2000" }, { "DOI": "10.1016/j.ebiom.2017.09.034", "article-title": "Chloroquine, a FDA-approved drug, prevents Zika virus infection and its associated congenital microcephaly in mice", "author": "Li", "doi-asserted-by": "crossref", "first-page": "189", "journal-title": "EBioMedicine", "key": "10.1016/j.mcpro.2025.101314_bib2", "volume": "24", "year": "2017" }, { "DOI": "10.1158/2159-8290.CD-18-0706", "article-title": "PPT1 promotes tumor growth and is the molecular target of chloroquine derivatives in cancer", "author": "Rebecca", "doi-asserted-by": "crossref", "first-page": "220", "issue": "2", "journal-title": "Cancer discovery", "key": "10.1016/j.mcpro.2025.101314_bib3", "volume": "9", "year": "2019" }, { "DOI": "10.1021/acscentsci.2c01325", "article-title": "A turn-on fluorescent amino acid sensor reveals chloroquine’s effect on cellular amino acids via inhibiting Cathepsin L", "author": "Smith", "doi-asserted-by": "crossref", "first-page": "980", "issue": "5", "journal-title": "ACS Central Science", "key": "10.1016/j.mcpro.2025.101314_bib4", "volume": "9", "year": "2023" }, { "DOI": "10.1128/AAC.01509-08", "article-title": "Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice", "author": "Keyaerts", "doi-asserted-by": "crossref", "first-page": "3416", "issue": "8", "journal-title": "Antimicrobial agents and chemotherapy", "key": "10.1016/j.mcpro.2025.101314_bib5", "volume": "53", "year": "2009" }, { "DOI": "10.1016/j.ijantimicag.2020.105938", "article-title": "New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?", "author": "Devaux", "doi-asserted-by": "crossref", "issue": "5", "journal-title": "International journal of antimicrobial agents", "key": "10.1016/j.mcpro.2025.101314_bib6", "volume": "55", "year": "2020" }, { "DOI": "10.1016/S1473-3099(03)00806-5", "article-title": "Effects of chloroquine on viral infections: an old drug against today's diseases", "author": "Savarino", "doi-asserted-by": "crossref", "first-page": "722", "issue": "11", "journal-title": "The Lancet infectious diseases", "key": "10.1016/j.mcpro.2025.101314_bib7", "volume": "3", "year": "2003" }, { "DOI": "10.1016/j.tmaid.2020.101735", "article-title": "Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review", "author": "Hashem", "doi-asserted-by": "crossref", "journal-title": "Travel medicine and infectious disease", "key": "10.1016/j.mcpro.2025.101314_bib8", "volume": "35", "year": "2020" }, { "DOI": "10.1002/j.1460-2075.1984.tb02195.x", "article-title": "Identification of the acidic compartment of Plasmodium falciparum‐infected human erythrocytes as the target of the antimalarial drug chloroquine", "author": "Yayon", "doi-asserted-by": "crossref", "first-page": "2695", "issue": "11", "journal-title": "The EMBO journal", "key": "10.1016/j.mcpro.2025.101314_bib9", "volume": "3", "year": "1984" }, { "DOI": "10.1016/0163-7258(93)90056-J", "article-title": "Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum", "author": "Slater", "doi-asserted-by": "crossref", "first-page": "203", "issue": "2-3", "journal-title": "Pharmacology & therapeutics", "key": "10.1016/j.mcpro.2025.101314_bib10", "volume": "57", "year": "1993" }, { "DOI": "10.1038/s41584-020-0372-x", "article-title": "Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology", "author": "Schrezenmeier", "doi-asserted-by": "crossref", "first-page": "155", "issue": "3", "journal-title": "Nature Reviews Rheumatology", "key": "10.1016/j.mcpro.2025.101314_bib11", "volume": "16", "year": "2020" }, { "DOI": "10.1016/j.cell.2020.02.052", "article-title": "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor", "author": "Hoffmann", "doi-asserted-by": "crossref", "first-page": "271", "issue": "2", "journal-title": "Cell", "key": "10.1016/j.mcpro.2025.101314_bib12", "volume": "181", "year": "2020" }, { "DOI": "10.1038/s41467-020-20457-w", "article-title": "Host and viral determinants for efficient SARS-CoV-2 infection of the human lung", "author": "Chu", "doi-asserted-by": "crossref", "first-page": "134", "issue": "1", "journal-title": "Nat Commun", "key": "10.1016/j.mcpro.2025.101314_bib13", "volume": "12", "year": "2021" }, { "DOI": "10.1016/j.cell.2020.09.033", "article-title": "SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2", "author": "Clausen", "doi-asserted-by": "crossref", "first-page": "1043", "issue": "4", "journal-title": "Cell", "key": "10.1016/j.mcpro.2025.101314_bib14", "volume": "183", "year": "2020" }, { "DOI": "10.1016/j.jbc.2021.100759", "article-title": "The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection", "author": "Carlos", "doi-asserted-by": "crossref", "journal-title": "J Biol Chem", "key": "10.1016/j.mcpro.2025.101314_bib15", "volume": "296", "year": "2021" }, { "DOI": "10.1126/science.abd3072", "article-title": "Neuropilin-1 is a host factor for SARS-CoV-2 infection", "author": "Daly", "doi-asserted-by": "crossref", "first-page": "861", "issue": "6518", "journal-title": "Science", "key": "10.1016/j.mcpro.2025.101314_bib16", "volume": "370", "year": "2020" }, { "DOI": "10.1038/s42255-020-00324-0", "article-title": "HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry", "author": "Wei", "doi-asserted-by": "crossref", "first-page": "1391", "issue": "12", "journal-title": "Nat Metab", "key": "10.1016/j.mcpro.2025.101314_bib17", "volume": "2", "year": "2020" }, { "DOI": "10.1021/acscentsci.0c01537", "article-title": "CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2", "author": "Amraei", "doi-asserted-by": "crossref", "first-page": "1156", "issue": "7", "journal-title": "ACS Cent Sci", "key": "10.1016/j.mcpro.2025.101314_bib18", "volume": "7", "year": "2021" }, { "DOI": "10.1038/s41422-020-00460-y", "article-title": "AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells", "author": "Wang", "doi-asserted-by": "crossref", "first-page": "126", "issue": "2", "journal-title": "Cell Res", "key": "10.1016/j.mcpro.2025.101314_bib19", "volume": "31", "year": "2021" }, { "DOI": "10.1016/j.cell.2023.06.005", "article-title": "TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry", "author": "Baggen", "doi-asserted-by": "crossref", "first-page": "3427", "issue": "16", "journal-title": "Cell", "key": "10.1016/j.mcpro.2025.101314_bib20", "volume": "186", "year": "2023" }, { "DOI": "10.1016/j.molcel.2020.04.022", "article-title": "A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells", "author": "Hoffmann", "doi-asserted-by": "crossref", "first-page": "779", "issue": "4", "journal-title": "Mol Cell", "key": "10.1016/j.mcpro.2025.101314_bib21", "volume": "78", "year": "2020" }, { "DOI": "10.1038/s41467-021-25729-7", "article-title": "A CRISPR/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses", "author": "Beumer", "doi-asserted-by": "crossref", "first-page": "5498", "issue": "1", "journal-title": "Nat Commun", "key": "10.1016/j.mcpro.2025.101314_bib22", "volume": "12", "year": "2021" }, { "DOI": "10.1126/sciadv.add3867", "article-title": "Altered host protease determinants for SARS-CoV-2 Omicron", "author": "Chan", "doi-asserted-by": "crossref", "first-page": "eadd3867", "issue": "3", "journal-title": "Sci Adv", "key": "10.1016/j.mcpro.2025.101314_bib23", "volume": "9", "year": "2023" }, { "DOI": "10.1128/jvi.00851-23", "article-title": "SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid models", "author": "Mykytyn", "doi-asserted-by": "crossref", "first-page": "e0085123", "issue": "8", "journal-title": "J Virol", "key": "10.1016/j.mcpro.2025.101314_bib24", "volume": "97", "year": "2023" }, { "DOI": "10.1016/j.ebiom.2021.103255", "article-title": "Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity", "author": "Hoffmann", "doi-asserted-by": "crossref", "journal-title": "EBioMedicine", "key": "10.1016/j.mcpro.2025.101314_bib25", "volume": "65", "year": "2021" }, { "DOI": "10.1038/s41586-020-2575-3", "article-title": "Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2", "author": "Hoffmann", "doi-asserted-by": "crossref", "first-page": "588", "issue": "7826", "journal-title": "Nature", "key": "10.1016/j.mcpro.2025.101314_bib26", "volume": "585", "year": "2020" }, { "DOI": "10.15252/embj.2021107821", "article-title": "TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells", "author": "Koch", "doi-asserted-by": "crossref", "issue": "16", "journal-title": "Embo j", "key": "10.1016/j.mcpro.2025.101314_bib27", "volume": "40", "year": "2021" }, { "DOI": "10.1080/22221751.2022.2117098", "article-title": "Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2", "author": "Hu", "doi-asserted-by": "crossref", "first-page": "2275", "issue": "1", "journal-title": "Emerg Microbes Infect", "key": "10.1016/j.mcpro.2025.101314_bib28", "volume": "11", "year": "2022" }, { "DOI": "10.3389/fcimb.2020.589505", "article-title": "Cathepsin L in COVID-19: from pharmacological evidences to genetics", "author": "Gomes", "doi-asserted-by": "crossref", "journal-title": "Frontiers in cellular and infection microbiology", "key": "10.1016/j.mcpro.2025.101314_bib29", "volume": "10", "year": "2020" }, { "DOI": "10.1016/j.pharmthera.2020.107587", "article-title": "Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients", "author": "Liu", "doi-asserted-by": "crossref", "journal-title": "Pharmacology & therapeutics", "key": "10.1016/j.mcpro.2025.101314_bib30", "volume": "213", "year": "2020" }, { "DOI": "10.1038/s41422-020-0282-0", "article-title": "Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro", "author": "Wang", "doi-asserted-by": "crossref", "first-page": "269", "issue": "3", "journal-title": "Cell Res", "key": "10.1016/j.mcpro.2025.101314_bib31", "volume": "30", "year": "2020" }, { "DOI": "10.1038/s42003-022-03841-8", "article-title": "Hydroxychloroquine blocks SARS-CoV-2 entry into the endocytic pathway in mammalian cell culture", "author": "Yuan", "doi-asserted-by": "crossref", "first-page": "958", "issue": "1", "journal-title": "Commun Biol", "key": "10.1016/j.mcpro.2025.101314_bib32", "volume": "5", "year": "2022" }, { "DOI": "10.1371/journal.ppat.1009212", "article-title": "Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2", "author": "Ou", "doi-asserted-by": "crossref", "first-page": "e1009212", "issue": "1", "journal-title": "PLoS pathogens", "key": "10.1016/j.mcpro.2025.101314_bib33", "volume": "17", "year": "2021" }, { "DOI": "10.1038/nprot.2014.138", "article-title": "The cellular thermal shift assay for evaluating drug target interactions in cells", "author": "Jafari", "doi-asserted-by": "crossref", "first-page": "2100", "issue": "9", "journal-title": "Nature protocols", "key": "10.1016/j.mcpro.2025.101314_bib34", "volume": "9", "year": "2014" }, { "DOI": "10.1016/j.jsb.2010.09.007", "article-title": "Structural basis for reversible and irreversible inhibition of human cathepsin L by their respective dipeptidyl glyoxal and diazomethylketone inhibitors", "author": "Shenoy", "doi-asserted-by": "crossref", "first-page": "14", "issue": "1", "journal-title": "Journal of structural biology", "key": "10.1016/j.mcpro.2025.101314_bib35", "volume": "173", "year": "2011" }, { "DOI": "10.3390/molecules25030698", "article-title": "A review of small molecule inhibitors and functional probes of human cathepsin L", "author": "Dana", "doi-asserted-by": "crossref", "first-page": "698", "issue": "3", "journal-title": "Molecules", "key": "10.1016/j.mcpro.2025.101314_bib36", "volume": "25", "year": "2020" }, { "DOI": "10.1016/0006-2952(74)90174-9", "article-title": "Lysosomotropic agents", "author": "De Duve", "doi-asserted-by": "crossref", "first-page": "2495", "issue": "18", "journal-title": "Biochemical pharmacology", "key": "10.1016/j.mcpro.2025.101314_bib37", "volume": "23", "year": "1974" }, { "DOI": "10.1073/pnas.2117576119", "article-title": "SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry", "author": "Yang", "doi-asserted-by": "crossref", "issue": "4", "journal-title": "Proceedings of the National Academy of Sciences", "key": "10.1016/j.mcpro.2025.101314_bib38", "volume": "119", "year": "2022" }, { "DOI": "10.1128/JVI.00415-08", "article-title": "Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide", "author": "Bosch", "doi-asserted-by": "crossref", "first-page": "8887", "issue": "17", "journal-title": "J Virol", "key": "10.1016/j.mcpro.2025.101314_bib39", "volume": "82", "year": "2008" }, { "DOI": "10.1074/jbc.M508381200", "article-title": "SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells", "author": "Huang", "doi-asserted-by": "crossref", "first-page": "3198", "issue": "6", "journal-title": "J Biol Chem", "key": "10.1016/j.mcpro.2025.101314_bib40", "volume": "281", "year": "2006" }, { "DOI": "10.1073/pnas.0505577102", "article-title": "Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry", "author": "Simmons", "doi-asserted-by": "crossref", "first-page": "11876", "issue": "33", "journal-title": "Proc Natl Acad Sci U S A", "key": "10.1016/j.mcpro.2025.101314_bib41", "volume": "102", "year": "2005" }, { "DOI": "10.1016/S2213-2600(21)00222-8", "article-title": "Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial", "author": "Tardif", "doi-asserted-by": "crossref", "first-page": "924", "issue": "8", "journal-title": "The Lancet Respiratory Medicine", "key": "10.1016/j.mcpro.2025.101314_bib42", "volume": "9", "year": "2021" }, { "DOI": "10.1111/jep.13614", "article-title": "Chinese herbal medicine (“3 medicines and 3 formulations”) for COVID‐19: rapid systematic review and meta‐analysis", "author": "Wang", "doi-asserted-by": "crossref", "first-page": "13", "issue": "1", "journal-title": "Journal of evaluation in clinical practice", "key": "10.1016/j.mcpro.2025.101314_bib43", "volume": "28", "year": "2022" } ], "reference-count": 43, "references-count": 43, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S153594762500413X" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Identification of Cathepsin L as the molecular target of hydroxychloroquine with chemical proteomics", "type": "journal-article", "update-policy": "https://doi.org/10.1016/elsevier_cm_policy" }